ScotusCrim is a recurring series by Rory Little focusing on intersections between the Supreme Court and criminal law. The ...

Abivax Announces Acceptance of 22 Abstracts Evaluating Obefazimod in Inflammatory Bowel Disease at ECCO 2026, Featuring an Oral Presentation on ...

Clarity Pharmaceuticals (ASX: CU6) (Clarity or Company), a clinical-stage radiopharmaceutical company with a mission to ...

Actuate Therapeutics, Inc. (NASDAQ: ACTU) ('Actuate” or the 'Company”), a clinical-stage biopharmaceutical company focused on ...

Abstracts for oral presentations should be submitted by March 9, 2026. AATCC reserves the right to accept, place on a waiting ...

Dr Yingyu Yang, a postdoctoral researcher at the University of Oxford’s Institute of Biomedical Engineering (IBME), has received the Best Oral Presentation Award at the MICCAI 2025 International ...

International debut underscores emerging role for macrophage checkpoint therapy in gastric cancer, triple-negative breast cancer, and other hard-to-treat solid tumors TAIPEI, SHANGHAI, AND SAN ...

Azacitidine and decitabine belong to a class of antineoplastic agents known as DNA methyltransferase inhibitors (DMTIs). Each is paired with cedazuridine, a cytidine deaminase inhibitor, to help the ...

The MarketWatch News Department was not involved in the creation of this content. -- Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled ...

The company monitors passenger feedback for risky driver behavior. Some accused of serious sexual assault had prior records ...

As AI tools like ChatGPT spread across campuses, colleges are rethinking exams with oral tests, handwritten work, and ...

Intraoral photobiomodulation therapy reduced severe oral mucositis and other adverse effects of radiation therapy in patients with HNC.